Clinical Research
Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of&nb...
May 26, 2023 | News
Avance Clinical CEO, Yvonne Lungershausen, Chief Scientific Officer Gabriel Kremmidiotis, and Head of Scientific and Regulatory Affairs Jorgen Mould are in...
May 25, 2023 | News
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional pro...
May 25, 2023 | News
Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...
May 24, 2023 | News
Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to del...
May 19, 2023 | News
With this qualification, Discovery gains access to Akoya's PhenoImager® HT workflows, which can provide insights into the tumor microenvironment (...
May 19, 2023 | News
- ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...
May 18, 2023 | News
This bi-directional integration enables clinicians using the BPAC eReferral system to transmit referrals from within their practice management solution (PM...
May 16, 2023 | News
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 ...
May 16, 2023 | News
TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million &nbs...
May 12, 2023 | News
Fujitsu today announced that it has conducted a joint research project with Takeda Pharmaceutical Company Limited and the National Cancer Center Japan to a...
May 12, 2023 | News
"We are pleased to enter this strategic collaboration with PharmaEssentia," Jingsong Wang, M.D., PhD, Chairman of Nona Biosciences, said, " PharmaEsse...
May 12, 2023 | News
CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary techno...
May 11, 2023 | News
-Boehringer Ingelheim announced that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 stu...
May 11, 2023 | News
Most Read
Bio Jobs
News